SLC18A2 and Parkinson disease: Unlike dopamine receptor blocking agents which block dopamine receptors, VMAT2 inhibitors act by depleting the presynaptic storage of dopamine and as such have not been associated with tardive dyskinesia, although they can cause transient acute dystonic reaction, akathisia, and drug-induced parkinsonism [27].